C Cohen, D J Sanger, G Perrault
Index: J. Pharmacol. Exp. Ther. 283 , 566, (1997)
Full Text: HTML
The ability of tiapride, a selective D2/D3 dopamine receptor antagonist, to exert discriminative stimulus control of responding was investigated by training rats to discriminate this drug (30 mg/kg) from saline in a two-lever, food-reinforcement procedure. Acquisition of tiapride discrimination required a relatively lengthy training period (mean of 76 sessions) but stable performance was maintained throughout the 18- month study. The dose of tiapride eliciting 50% tiapride-lever choice (ED50) was 2.2 mg/kg. After determination of the dose-effect curve with tiapride, substitution tests with several dopamine antagonists and other reference compounds were performed. All dopamine antagonists, including amisulpride (ED50 4 mg/kg), sulpiride (18 mg/kg), sultopride (1.5 mg/kg), clebopride (0.13 mg/kg), raclopride (0.16 mg/kg), metoclopramide (1.4 mg/kg), remoxipride (4.8 mg/kg), pimozide (2.7 mg/kg), thioridazine (3.4 mg/kg), olanzapine (0.97 mg/kg), chlorpromazine (1.9 mg/kg), risperidone (0.22 mg/kg) and haloperidol (0.14 mg/kg), except clozapine (>10 mg/kg), produced dose-dependent substitution for tiapride. Tiapride-like stimulus effects were observed at doses that decreased response rates. However, ED50 values for substitution by tiapride, amisulpride, sulpiride, sultopride, pimozide, clebopride and thioridazine were lower than ED50 values for decreasing responding. Additional studies were conducted to evaluate the ability of direct and indirect dopamine agonists to attenuate the tiapride discriminative stimulus. Pretreatment with d-amphetamine and nomifensine antagonized the discriminative stimulus effects of tiapride. Quinpirole, 7-OH-DPAT, bromocriptine and apomorphine partially blocked the stimulus effects of tiapride whereas SKF 38393 did not affect the discrimination. These results from substitution and antagonism tests indicated that the discriminative effects of tiapride are mediated by activity at D2/D3 dopamine receptors.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
Tiapride
CAS:51012-32-9 |
C15H24N2O4S |
Serotonergic signalling suppresses ataxin 3 aggregation and ...
2015-11-01 [Brain 138 , 3221-37, (2015)] |
German insurer finds a third of people over 65 take five or ...
2013-01-01 [BMJ 346 , f3905, (2013)] |
Pharmacological treatment of tic disorders and Tourette Synd...
2013-05-01 [Neuropharmacology 68 , 143-9, (2013)] |
Tiapride. A review of its pharmacology and therapeutic poten...
1994-06-01 [Drugs 47 , 1010, (1994)] |
Clinical and neurobiological findings in children suffering ...
2015-01-13 [Eur. Arch. Psychiatry Neurol. Sci. 237(4) , 223-9, (1988)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved